Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study

BACKGROUND: Following positive results from the Phase III CHEST-1 study in patients with inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH), the Phase IIIb CTEPH early access study (EAS) was designed to assess the safety and tolerability of riociguat in real-wor...

Full description

Saved in:
Bibliographic Details
Published in:BMC Pulm Med
Main Authors: McLaughlin, Vallerie V., Jansa, Pavel, Nielsen-Kudsk, Jens E., Halank, Michael, Simonneau, Gérald, Grünig, Ekkehard, Ulrich, Silvia, Rosenkranz, Stephan, Gómez Sánchez, Miguel A., Pulido, Tomás, Pepke-Zaba, Joanna, Barberá, Joan Albert, Hoeper, Marius M., Vachiéry, Jean-Luc, Lang, Irene, Carvalho, Francine, Meier, Christian, Mueller, Katharina, Nikkho, Sylvia, D’Armini, Andrea M.
Format: Artigo
Language:Inglês
Published: BioMed Central 2017
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5745920/
https://ncbi.nlm.nih.gov/pubmed/29282032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-017-0563-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items